Literature DB >> 2893983

The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.

C Nanoff1, M Freissmuth, W Schütz.   

Abstract

On the basis of saturation binding studies on rat cardiac microsomes, which contained a mixed population of beta-adrenoceptor subtypes, [3H]CGP-12177 is presumed to be a non-selective beta-adrenergic radioligand. However, saturation binding studies carried out in the presence of subtype-saturating concentrations of the beta 2-selective antagonist ICI 118,551 and the beta 1-selective antagonist ICI 89,406, respectively, revealed a KD for beta 1-adrenoceptors of 0.33 +/- 0.02 nmol/l and a KD for beta 2-adrenoceptors of 0.90 +/- 0.14 nmol/l. Competition experiments with the highly selective antagonists revealed greatly different competition binding curves in the presence of either [3H]CGP-12177 or (-)[125I]iodocyanopindolol (ICYP), a beta-adrenergic radioligand considered to be as non-selective as [3H]CGP-12177. The following results are further suggestive for a selectivity of [3H]CGP-12177 for beta 1-adrenoceptors: (1) Using non-linear regression analysis, a significantly lower selectivity (expressed as the ratio of the IC50 for beta 2-adrenoceptors to the IC50 for beta 1-adrenoceptors) as well as a larger proportion of beta 1-adrenoceptors were calculated by competition of the beta 1-selective antagonist ICI 89,406 with [3H]CGP-12177 binding than by competition of ICI 89,406 with ICYP binding; (2) reducing the [3H]CGP-12177 concentration from 2 to 0.4 nmol/l, competition experiments with ICI 89,406 led to an increase in the estimated selectivity of the competitor and in the estimated proportion of beta 1-adrenoceptors; (3) reverse findings were obtained with ICI 118,551, a beta 2-selective antagonist.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893983     DOI: 10.1007/bf00169308

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Direct assessment of beta-adrenergic receptors in intact rat adipocytes by binding of [3H]CGP 12177. Evidence for agonist high-affinity binding complex and for beta 1 and beta 2 receptor subtypes.

Authors:  D Lacasa; B Agli; Y Giudicelli
Journal:  Eur J Biochem       Date:  1985-01-15

2.  A general strategy for parameter estimation from isosteric and allosteric-kinetic data and binding measurements.

Authors:  J G Reich; G Wangermann; M Falck; K Rohde
Journal:  Eur J Biochem       Date:  1972-04-11

3.  Determination of the desensitization of beta-adrenergic receptors by [3H]CGP-12177.

Authors:  C Hertel; P Müller; M Portenier; M Staehelin
Journal:  Biochem J       Date:  1983-12-15       Impact factor: 3.857

4.  Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.

Authors:  A Wellstein; D Palm; G Wiemer; M Schäfer-Korting; E Mutschler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Improved evaluation of binding of ligands to membranes containing several receptor-subtypes.

Authors:  B Ehle; H Lemoine; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

6.  Binding characteristics of (+)-, (+/-)- and (-)-[125iodo] cyanopindolol to guinea-pig left ventricle membranes.

Authors:  D Hoyer; G Engel; R Berthold
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-03       Impact factor: 3.000

7.  Model testing in radioligand/receptor interaction by Monte Carlo simulation.

Authors:  E Bürgisser
Journal:  J Recept Res       Date:  1983

8.  Evidence for two specific affinity states of 3H-antagonist binding to cardiac beta-adrenergic receptors and influence of Gpp(NH)p.

Authors:  P H Lang; B Lemmer
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1985

9.  Evidence for intravesicular beta-adrenergic receptors in membrane fractions from desensitized cells: binding of the hydrophilic ligand CGP-12177 only in the presence of alamethicin.

Authors:  C Hertel; M Staehelin; J P Perkins
Journal:  J Cyclic Nucleotide Protein Phosphor Res       Date:  1983

10.  Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes.

Authors:  D S Heron; M Shinitzky; M Hershkowitz; D Samuel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  13 in total

1.  Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.

Authors:  D Sarsero; P Molenaar; A J Kaumann; N S Freestone
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Preclinical evaluation of an 18F-labelled beta1-adrenoceptor selective radioligand based on ICI 89,406.

Authors:  Marilyn P Law; Stefan Wagner; Klaus Kopka; Christiane Renner; Victor W Pike; Otmar Schober; Michael Schäfers
Journal:  Nucl Med Biol       Date:  2010-05       Impact factor: 2.408

3.  Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein.

Authors:  Zahida Parveen; Thomas Stockner; Caterina Bentele; Sandra Pferschy; Martin Kraupp; Michael Freissmuth; Gerhard F Ecker; Peter Chiba
Journal:  Mol Pharmacol       Date:  2010-12-21       Impact factor: 4.436

4.  Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.

Authors:  Martin D Lowe; James A Lynham; Andrew A Grace; Alberto J Kaumann
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

5.  Reversal of myocyte hypertrophy by ventricular unloading: cardiac improvement without adrenergic receptor up-regulation and relocalization.

Authors:  Pippa M Schnee; Naeema Shah; Marianne Bergheim; Brian J Poindexter; L Max Buja; Timothy J Myers; Branislav Radovancevic; O Howard Frazier; Roger J Bick
Journal:  MedGenMed       Date:  2006-05-16

6.  Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.

Authors:  Jillian G Baker; Ian P Hall; Stephen J Hill
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.

Authors:  M P Law
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Beta-adrenoceptor subtypes in young and old rat ventricular myocytes: a combined patch-clamp and binding study.

Authors:  E Cerbai; L Guerra; K Varani; M Barbieri; P A Borea; A Mugelli
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

9.  Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.

Authors:  Jürgen F Heubach; Marianne Blaschke; Sian E Harding; Ursula Ravens; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-04       Impact factor: 3.000

10.  Are [O-methyl-11C]derivatives of ICI 89,406 beta1-adrenoceptor selective radioligands suitable for PET?

Authors:  Marilyn P Law; Stefan Wagner; Klaus Kopka; Victor W Pike; Otmar Schober; Michael Schäfers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-29       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.